Instead of relying on the cell’s repair mechanisms, the vaccinia virus MacGyvers a tool for DNA repair from one that it already uses to copy DNA,...
Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive...
With rare exceptions, each of the trillions of cells in our bodies carries an exact duplicate of the human genome, which contains between 20,000 and 25,000...
SAN FRANCISCO, CA—May 12, 2022—Viruses in the herpesvirus family are leading causes of birth defects, blindness, and failed organ transplants worldwide....
• In an international collaboration, researchers led by Nuria Montserrat, ICREA Research Professor at IBEC, have generated human mini-kidneys that simulate...
Current COVID-19 booster shots have a problem: they last only about four months and appear to have limited efficacy in a vaccinated population. Clearly,...
Danish drugmaker Novo Nordisk has traditionally generated its pipeline mainly from internal R&D, but a new alliance with The post Novo Nordisk forges...
Ribonucleic acids (RNAs), which decode the genetic code stored in DNA and produce proteins, fold into diverse structures to govern fundamental biological...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
In this GEN webinar, sponsored by Precision NanoSystems, our distinguished speaker, Dr. Ethan Settembre, will introduce us to the intricacies of saRNA...
Could these health care stocks be the remedy to investors’ recent stock market pains? The post Best Stocks To Buy Now? 5 Health Care Stocks In...
Moderna is still fending off patent challenges over the lipid nanoparticle delivery system used in its COVID-19 vaccine, Spikevax.
COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as they...
Uncharacterised and so far rare cases of unexplained severe liver inflammation among young children. These cases of unexplained hepatitis have been appearing...
Over time, cancer cells can evolve to become resistant to treatment, more aggressive, and metastatic—capable of spreading to additional sites in the...
The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by...
BINGHAMTON, N.Y. — When the COVID-19 pandemic emerged in early 2020, ultraviolet radiation became one of the go-to methods for preventing the spread...
Over 800 sites across the US report coronavirus data from sewage to the CDC. Here’s how this kind of surveillance system works and what it can...
Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development...
Molecular profiles that “zoom in” (to reveal the contents of single cells) and “zoom out” (to reveal cell-cell relationships in tissue samples)...
In the vaccine industry, as well as in the broader pharmaceutical industry, expectations for mRNA technology used to be fairly modest. But all that changed...
GSK’s strong Q1 driven by COVID-19, returning demand for shingles vaccine Published: Apr 27, 2022 By Mark Terry BioSpace GlaxoSmithKline exceeded expectations...
Moderna co-founder Robert Langer developed the process that made COVID-19 vaccines possible. He spoke about his journey helping develop the science for...
Hydrothermal vents in the deep sea are well-known oases of life. Many living creatures thrive there, benefiting from the nutrient-rich fluids that are...
The International Vaccine Institute (IVI) hosted the 2022 Award Ceremony of the IVI-SK bioscience Park MahnHoon Award today, honoring Dr. Tore Godal, special...
Uncahareistsed and so far rare cases of liver inflammation (hepatitis) have been appearing in low numbers among young children worldwide since January...
Bloomington, Indiana, is the home of Hoosiers basketball – and the center of Catalent’s biologics drug substance manufacturing operations. And while...
Arcturus Therapeutics announced positive Phase III trial results for the company's mRNA vaccine candidate ARCT-154, which is intended to prevent COVID-19...
CHAMPAIGN, Ill. — A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate...
Coronavirus vaccine stocks worth knowing as Covid-19 remains a global public health emergency. The post Best Stocks To Invest In Now? 3 Coronavirus Vaccine...